Trial · NCT00523341
Adverse events1,956
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,956
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Placebo/ Denosumab 60 mg Q6M | 141 | 2,206 | |
| other | Anaemia | Blood and lymphatic system disorders | Denosumab/ Denosumab 60 mg Q6M | 168 | 2,343 | |
| other | Vertigo | Ear and labyrinth disorders | Placebo/ Denosumab 60 mg Q6M | 138 | 2,206 | |
| other | Vertigo | Ear and labyrinth disorders | Denosumab/ Denosumab 60 mg Q6M | 140 | 2,343 | |
| other | Cataract | Eye disorders | Placebo/ Denosumab 60 mg Q6M | 319 | 2,206 | |
| other | Cataract | Eye disorders | Denosumab/ Denosumab 60 mg Q6M | 317 | 2,343 | |
| other | Constipation | Gastrointestinal disorders | Placebo/ Denosumab 60 mg Q6M | 141 | 2,206 | |
| other | Constipation | Gastrointestinal disorders | Denosumab/ Denosumab 60 mg Q6M | 118 | 2,343 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo/ Denosumab 60 mg Q6M | 139 | 2,206 | |
| other | Diarrhoea | Gastrointestinal disorders | Denosumab/ Denosumab 60 mg Q6M | 152 | 2,343 | |
| other | Bronchitis | Infections and infestations | Placebo/ Denosumab 60 mg Q6M | 206 | 2,206 | |
| other | Bronchitis | Infections and infestations | Denosumab/ Denosumab 60 mg Q6M | 226 | 2,343 | |
| other | Cystitis | Infections and infestations | Placebo/ Denosumab 60 mg Q6M | 194 | 2,206 | |
| other | Cystitis | Infections and infestations | Denosumab/ Denosumab 60 mg Q6M | 212 | 2,343 | |
| other | Influenza | Infections and infestations | Placebo/ Denosumab 60 mg Q6M | 179 | 2,206 | |
| other | Influenza | Infections and infestations | Denosumab/ Denosumab 60 mg Q6M | 192 | 2,343 | |
| other | Nasopharyngitis | Infections and infestations | Placebo/ Denosumab 60 mg Q6M | 372 | 2,206 | |
| other | Nasopharyngitis | Infections and infestations | Denosumab/ Denosumab 60 mg Q6M | 385 | 2,343 | |
| other | Pneumonia | Infections and infestations | Placebo/ Denosumab 60 mg Q6M | 137 | 2,206 | |
| other | Pneumonia | Infections and infestations | Denosumab/ Denosumab 60 mg Q6M | 167 | 2,343 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00523341/events